Active — Not RecruitingNot Applicable

Cohort of Hospitalized Patients Suspected of Leptospirosis

France200 participantsStarted 2021-01-06

Plain-language summary

COLEPT is a prospective interventional study that intends to better inform about leptospirosis, a neglected zoonotic infectious disease. During prospective follow-up of hospitalized acute leptospirosis cases, the participants will be assessed during 1 year for epidemiological, clinical, bacteriological and immunological data. Main intervention consists in blood sampling and biological bank constitution.

Who can participate

Age range1 Day

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinico-biological manifestations compatible with acute leptospirosis OR proven leptospirosis with serological testing or PCR * onset of symptoms within 21 days * participant benefits of health insurance Exclusion Criteria: * participant's refusal, or refusal from his relatives in case of major incapacity of the eligible participant precluding expression of his will (coma, stay in intensive care unit))

What they're measuring

disease severity

Timeframe: 0 to 21 days after onset of symptoms

Trial details

NCT IDNCT04034550

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2027-01-06

View on ClinicalTrials.gov More Leptospirosis trials